3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
3
Gastrointestinal
2
Plasma cell
1
Other hematologic neoplasm
1
NET
1
Lymphoid
1
Gynecologic
1
Endocrine
1
Conditions
Multiple Myeloma
339
Neoplasms, Plasma Cell
62
Lymphoma
38
Recurrence
27
Leukemia
26
Lymphoma, Non-Hodgkin
21
Leukemia, Myeloid, Acute
20
Hodgkin Disease
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Myelodysplastic Syndromes
17
Leukemia, Lymphocytic, Chronic, B-Cell
17
Lymphoma, Follicular
16
Lymphoma, Large B-Cell, Diffuse
15
Immunoglobulin Light-chain Amyloidosis
14
Lymphoma, B-Cell, Marginal Zone
13
Hematologic Neoplasms
13
Lymphoma, Mantle-Cell
12
Burkitt Lymphoma
12
Lymphoma, Large-Cell, Immunoblastic
10
Neoplasms
8
Myeloproliferative Disorders
8
Leukemia, Myeloid, Chronic-Phase
8
Leukemia, Myeloid, Accelerated Phase
8
Blast Crisis
8
Neoplasm, Residual
7
Hematologic Diseases
7
Pancreatic Neoplasms
6
Lymphoma, T-Cell, Cutaneous
6
Lymphoma, B-Cell
6
Lung Neoplasms
6
Interventions
Sequence Analysis, DNA
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Genetic Predisposition to Disease
×
Plasma cell
×
Clear all
NCT05331313
2022-04-15
MMSPORADGEN
Hospices Civils de Lyon
Unknown
1,000 enrolled